Loading…
Reported covered position: Deputy Chief of Staff, Rep. Richard Hudson
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Affordable Prescriptions for Patients Act of 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act
Affordable Prescriptions for Patients Act of 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. 150, Affordable Prescriptions for Patients Act, Patent Protection, general IP issues
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOVO NORDISK INC. via NOVO NORDISK INC.
2023 · second_quarter · Q2
S. 150, Affordable Prescriptions for Patients Act, Patent Protection, general IP issues
Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act
Source: Senate LDA
Affordable Prescriptions for Patients Act of 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. 150, Affordable Prescriptions for Patients Act, Patent Protection, general IP issues
Affordable Prescriptions for Patients Act of 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions; Part D redesign
H.R. 5376, the Build Back Better Act H.R. 2471, Consolidated Appropriations Act 2022 deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions; Part D redesign
H.R. 5376, the Build Back Better Act H.R. 2471, Consolidated Appropriations Act 2022 deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Build Back Better Act H.R. 2471, Consolidated Appropriations Act 2022 deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R.5376 Build Back Better Act regarding provisions related to corporate tax
H.R.5376 Inflation Reduction Act regarding provisions related to corporate tax
H.R. 5376, the Build Back Better Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions; Part D redesign
H.R.5376 Build Back Better Act regarding provisions related to corporate tax
H.R.5376 Inflation Reduction Act regarding provisions related to corporate tax
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 5376, the Build Back Better Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Build Back Better Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Build Back Better Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Build Back Better Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions; Part D redesign
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 5376, the Build Back Better Act H.R. 2471, Consolidated Appropriations Act 2022 deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
H.R.5376 Build Back Better Act regarding provisions related to corporate tax
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
Obesity, Treat and Reduce Obesity Act, IRA implementation
Labor-HHS Appropriations Bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2023 · first_quarter · Q1
Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act
Labor-HHS Appropriations Bill
S. 150, Affordable Prescriptions for Patients Act, Patent Protection, general IP issues
Obesity, Treat and Reduce Obesity Act, IRA implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2022 · fourth_quarter · Q4
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
No bill, General issues related to copyright and patent protection
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions; Part D redesign
H.R.5376 Inflation Reduction Act regarding provisions related to corporate tax
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2022 · third_quarter · Q3
No bill, General issues related to copyright and patent protection
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R.5376 Inflation Reduction Act regarding provisions related to corporate tax
H.R. 5376, the Inflation Reduction Act deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics and bio-pharmaceutical provisions H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 and issues related to the coverage of obesity therapeutics
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Inflation Reduction Act regarding bio-pharmaceutical provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2022 · second_quarter · Q2
H.R. 5376, the Build Back Better Act H.R. 2471, Consolidated Appropriations Act 2022 deficit reduction, reconciliation S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
No bill, General issues related to copyright and patent protection
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
H.R. 5376, the Build Back Better Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Medication affordability and access, general diabetes prevention, obesity S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R.5376 Build Back Better Act regarding provisions related to corporate tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2022 · first_quarter · Q1
S. Con. Res. 5 (117)/H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare; H.R.2471 Consolidated Appropriations Act 2022 and issues related to the coverage of obesity therapeutics
S.3700/H.R. 6833 Affordable Insulin Now Act and issues related to affordability; No bill, issues related to medication affordability and access, general diabetes prevention, obesity; no bill, issues related to 340B
H.R.5376 Build Back Better Act regarding provisions related to corporate tax
NOVO NORDISK INC. via NOVO NORDISK INC.
2021 · fourth_quarter · Q4
H.R.5376 Build Back Better Act regarding provisions related to corporate tax
National Defense Authorization Act for Fiscal Year 2022 and issues related to implementation
No bill, issues related to medication affordability and access, general diabetes prevention, obesity
NOVO NORDISK INC. via NOVO NORDISK INC.
2021 · third_quarter · Q3
No bill, issues related to corporate tax
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
no bill, issues related to 340B
NOVO NORDISK INC. via NOVO NORDISK INC.
2021 · second_quarter · Q2
No bill, issues related to medication affordability and access, general diabetes prevention, obesity
No bill, General issues related to copyright and patent protection
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
NOVO NORDISK INC. via NOVO NORDISK INC.
2021 · first_quarter · Q1
No bill, issues related to corporate tax
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
No bill, issues related to medication affordability and access, general diabetes prevention, obesity
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
No bill, General issues related to copyright and patent protection
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
No bill, General issues related to copyright and patent protection
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
no bill, issues related to 340B
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign; H.R.5376 Build Back Better Act regarding bio-pharmaceutical provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign
No bill, issues related to medication affordability and access, general diabetes prevention, obesity
National Defense Authorization Act for Fiscal Year 2022 and issues related to implementation
No bill, General issues related to copyright and patent protection
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
National Defense Authorization Act for Fiscal Year 2022 and issues related to implementation
No bill, issues related to corporate tax
no bill, issues related to 340B
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare
no bill, issues related to 340B
No bill, General issues related to copyright and patent protection
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE